GLP-1 (semaglutide or tirzepatide) Therapy in Older Adults: Balancing Benefit & Risk Beyond Age 65 Joshua Silva, MD Dec 12, 2025 4 min read Medically authored by Joshua Silva, MD | Evidence-Based Weight Loss at Potere Health MD Last clinically updated: December 2025 Many discussions about GLP-1 medications in older adults come from friends, family, or acquaintances , as well as online forums, news stories, and social media posts
(Prices vary)
Dall'Asen tested the brighter red hue, Boasty, and enjoyed the comfortable, customizable formula
alone, adoption is expected to grow to 31.5 million people approximately 9% of the population by 2035
Based on published clinical data, patients averaged 20.12 pounds of weight loss at 12 weeks
development halted at Phase 2 in the late 1990s due to safety profile Reference sources (PubMed) Dorr RT